Last reviewed · How we verify
Platinum doublet chemotherapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Platinum doublet chemotherapy (Platinum doublet chemotherapy) — Fondazione Ricerca Traslazionale.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Platinum doublet chemotherapy TARGET | Platinum doublet chemotherapy | Fondazione Ricerca Traslazionale | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Platinum doublet chemotherapy CI watch — RSS
- Platinum doublet chemotherapy CI watch — Atom
- Platinum doublet chemotherapy CI watch — JSON
- Platinum doublet chemotherapy alone — RSS
Cite this brief
Drug Landscape (2026). Platinum doublet chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/platinum-doublet-chemotherapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab